Ascentage Pharma Group International Ownership | Who Owns Ascentage Pharma Group International?
Ascentage Pharma Group International Ownership Summary
Ascentage Pharma Group International is owned by 0.02% institutional investors, and 99.98% retail investors. Srs capital advisors is the largest institutional shareholder, holding 0.00% of AAPG shares. ProFunds UltraChina Inv is the top mutual fund, with 0.00% of its assets in Ascentage Pharma Group International shares.
AAPG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ascentage Pharma Group International | 0.02% | - | 99.98% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Srs capital advisors | 1.23K | 0.00% | $20.06K |
| Newedge advisors | 455.00 | 0.00% | $7.42K |
| Morgan stanley | 394.00 | 0.00% | $6.42K |
| Nuveen | 79.00 | 0.00% | $1.21K |
| Citigroup | 1.00 | - | $17.00 |
| Blackrock funding, inc. /de | 1.00 | - | $16.00 |
| Xy capital | - | - | - |
| Caitong asset management | 1.00 | - | $16.00 |
| Tower research capital llc (trc) | - | - | - |
| Eversource wealth advisors | 24.00 | - | $391.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Srs capital advisors | 1.23K | 0.00% | $20.06K |
| Tower research capital llc (trc) | - | - | - |
| Eversource wealth advisors | 24.00 | - | $391.00 |
| Ubs group | - | - | - |
| Newedge advisors | 455.00 | - | $7.42K |
| Citigroup | 1.00 | - | $17.00 |
| Morgan stanley | 394.00 | - | $6.42K |
| Blackrock funding, inc. /de | 1.00 | - | $16.00 |
| Nuveen | 79.00 | - | $1.21K |
| Xy capital | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Srs capital advisors | 1.23K | 0.00% | 1.23K |
| Newedge advisors | 455.00 | - | 455.00 |
| Nuveen | 79.00 | - | 79.00 |
| Citigroup | 1.00 | - | 1.00 |
| Eversource wealth advisors | 24.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Xy capital | - | - | -13.01K |
| Morgan stanley | 394.00 | - | -525.00 |
| Tower research capital llc (trc) | - | - | -518.00 |
| Ubs group | - | - | -15.00 |
| Blackrock funding, inc. /de | 1.00 | - | -5.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Srs capital advisors | 1.23K | 0.00% | 1.23K | $20.06K |
| Newedge advisors | 455.00 | - | 455.00 | $7.42K |
| Nuveen | 79.00 | - | 79.00 | $1.21K |
| Citigroup | 1.00 | - | 1.00 | $17.00 |
Sold Out
| Holder | Change |
|---|---|
| Ubs group | -15.00 |
| Tower research capital llc (trc) | -518.00 |
| Xy capital | -13.01K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 7 | 16.67% | 15,006 | -50.37% | - | 1511.04% | 4 | 100.00% | 2 | -33.33% |
| Mar 31, 2026 | 6 | -45.45% | 30,234 | -36.70% | - | 1226.74% | 2 | -50.00% | 3 | -40.00% |
| Dec 31, 2025 | 11 | -21.43% | 47,764 | -49.23% | - | 424.77% | 4 | -55.56% | 5 | 25.00% |
| Sep 30, 2025 | 14 | 27.27% | 94,076 | 15.05% | - | 1200.94% | 9 | - | 4 | 100.00% |
| Jun 30, 2025 | 11 | 83.33% | 81,771 | -65.53% | - | 97.07% | 9 | 50.00% | 2 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ProFunds UltraChina Inv | 3.96K | 0.00% | -1.16K |
| Fidelity Nasdaq Composite Index | 1.56K | 0.00% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
AAPG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools